The New York Times - Business:
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.
This post first appeared in The New York Times - Business. Read the original article.
In China, Rare Dissent Over a Program to Save on Drug Costs
Post navigation
Previous Post
Pete Hegseth Confirmed As Trump’s Defense Secretary